" class="no-js "lang="en-US"> Elephas Biosciences - Medtech Alert
Thursday, September 18, 2025
Elephas Biosciences | Pharmtech Focus

Elephas Biosciences

About Elephas Biosciences

Elephas Biosciences

Disruption in healthcare is being accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision making and accelerate drug development. We plan to use the power of our platform to deliver a global solution that can revolutionize cancer treatment for every individual.

Related Story

Elephas Announces $41.5 Million in Series B Funding

September 7 2022

Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $41.5 million in Series […]